← Back to Influence Map
Entity DossierOrganization
NOVARTIS
DC · US
pharmaceuticals
Tracked direct giving
$0
LDA reported lobbying spend
$8,670,000
Connections
13
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
HCRHealth Issues
$16.4MMMMMedicare/Medicaid
$14.8MTRDTrade
$13.5MBUDBudget/Appropriations
$13.2MTAXTaxation/Internal Revenue Code
$13.2MCPTCopyright/Patent/Trademark
$12.7MLBRLabor/Employment
$12.4MSCIScience
$960KPHAPharmacy
$40KMEDMedical/Disease Research
$40KLobbying Firms Retained
In-house lobbyists (filed as its own registrant)$12.4M
BROWNSTEIN HYATT FARBER SCHRECK, LLP$840K
BGR GOVERNMENT AFFAIRS$780K
TARPLIN, DOWNS & YOUNG, LLC$780K
TIBER CREEK HEALTH STRATEGIES, INC.$720K
MONUMENT ADVOCACY$480K
DLA PIPER LLP (US)$280K
Corcoran & Associates, Inc. dba Corcoran Partners$270K
RESOLUTION PUBLIC AFFAIRS, LLC$270K
EAST END GROUP, LLC$45K
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Retained | TIBER CREEK HEALTH STRATEGIES, INC. | Hired TIBER CREEK HEALTH STRATEGIES, INC. to lobby on PBM Reform Act | Source |
| Retained | BGR GOVERNMENT AFFAIRS | Hired BGR GOVERNMENT AFFAIRS to lobby on PBM Reform Act | Source |
| Lobbied on | Pharmacy Benefit Manager Reform Act | LDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $20,000 | Source |
| Retained | Brownstein Hyatt Farber Schreck | Hired BROWNSTEIN HYATT FARBER SCHRECK, LLP to lobby on PBM Reform Act | Source |
| Lobbied on | MARCH-IN Rights Proposal (NIH Framework) | LDA filing: lobbied on NIH March-In Rights, period 3rd Quarter (July 1 - Sep 30), reported amount $1,360,000 | Source |
| Retained | TARPLIN, DOWNS & YOUNG, LLC | Hired TARPLIN, DOWNS & YOUNG, LLC to lobby on Pharmaceuticals | Source |
| Retained | Corcoran & Associates, Inc. dba Corcoran Partners | Hired CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS to lobby on Pharmaceuticals | Source |
| Commented on | Centers for Medicare & Medicaid Services | Public comment on CMS-2024-0157: Medicare Program: Alternative Payment Model Updates and the Increasing Organ Transplant Access Model | Source |
| Retained | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Hired BROWNSTEIN HYATT FARBER SCHRECK, LLP to lobby on PBM Reform Act | Source |
| Retained | EAST END GROUP, LLC | Hired EAST END GROUP, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | MONUMENT ADVOCACY | Hired MONUMENT ADVOCACY to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | RESOLUTION PUBLIC AFFAIRS, LLC | Hired RESOLUTION PUBLIC AFFAIRS, LLC to lobby (3rd Quarter (July 1 - Sep 30) 2023) | Source |
| Retained | DLA PIPER LLP (US) | Hired DLA PIPER LLP (US) to lobby (2nd Quarter (Apr 1 - June 30) 2025) | Source |